Metraipolis › archive › dc_52b80cf3136c

Effect of Pemafibrate on Metabolic Dysfunction-Associated Steatotic Liver Disease: A Nationwide Multicenter Study — Europe PMC PMID:40932833

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40932833
DOI
10.1002/jgh3.70277
License (as archived)
solo-consultazione
Archived
2026-11-10T01:06:31.213Z
SHA-256 of the archived text
2b7e147c4d99de50fa8df7c58fa974d9e9dc473a2fbdad7607129c037eab3b01
Stable URL of this page
https://metraipolis.com/documento/dc_52b80cf3136c

How to cite

Effect of Pemafibrate on Metabolic Dysfunction-Associated Steatotic Liver Disease: A Nationwide Multicenter Study — Europe PMC PMID:40932833 — Europe PMC (en), https://europepmc.org/article/MED/40932833 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_52b80cf3136c (Metraipolis archive dc_52b80cf3136c, sha256 2b7e147c4d99de50fa8df7c58fa974d9e9dc473a2fbdad7607129c037eab3b01)
BibTeX
@misc{dc52b80cf3136c,
  title = {Effect of Pemafibrate on Metabolic Dysfunction-Associated Steatotic Liver Disease: A Nationwide Multicenter Study — Europe PMC PMID:40932833},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40932833},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_52b80cf3136c; sha256 2b7e147c4d99de50fa8df7c58fa974d9e9dc473a2fbdad7607129c037eab3b01},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40932833. Agents can read the archived copy with the MCP tool read_document.